Annual Total Long Term Liabilities
$0.00
$0.000.00%
December 31, 2024
Summary
- As of February 27, 2025, NVCT annual total long term liabilities is $0.00, unchanged on December 31, 2024.
- During the last 3 years, NVCT annual total long term liabilities has fallen by -$15.25 million (-100.00%).
- NVCT annual total long term liabilities is now -100.00% below its all-time high of $15.25 million, reached on December 31, 2021.
Performance
NVCT Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$0.00
$0.000.00%
December 31, 2024
Summary
- As of February 27, 2025, NVCT quarterly total long term liabilities is $0.00, unchanged on December 31, 2024.
- Over the past year, NVCT quarterly long term liabilities has stayed the same.
- NVCT quarterly long term liabilities is now -100.00% below its all-time high of $15.25 million, reached on September 30, 2021.
Performance
NVCT Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
NVCT Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | 0.0% | 0.0% |
| 3 y3 years | -100.0% | 0.0% |
| 5 y5 years | 0.0% | 0.0% |
NVCT Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -100.0% | at low | -100.0% | at low |
| 5 y | 5-year | -100.0% | at low | -100.0% | at low |
| alltime | all time | -100.0% | at low | -100.0% | at low |
Nuvectis Pharma Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2024 | - | $0.00(0.0%) |
| Jun 2024 | - | $0.00(0.0%) |
| Mar 2024 | - | $0.00(0.0%) |
| Dec 2023 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2023 | - | $0.00(0.0%) |
| Jun 2023 | - | $0.00(0.0%) |
| Mar 2023 | - | $0.00(0.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $0.00(-100.0%) | $0.00(0.0%) |
| Sep 2022 | - | $0.00(0.0%) |
| Jun 2022 | - | $0.00(0.0%) |
| Mar 2022 | - | $0.00(-100.0%) |
| Dec 2021 | $15.25 M(>+9900.0%) | $15.25 M(0.0%) |
| Sep 2021 | - | $15.25 M(+35.8%) |
| Jun 2021 | - | $11.22 M |
| Dec 2020 | $0.00 | - |
FAQ
- What is Nuvectis Pharma annual total long term liabilities?
- What is the all time high annual total long term liabilities for Nuvectis Pharma?
- What is Nuvectis Pharma annual total long term liabilities year-on-year change?
- What is Nuvectis Pharma quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Nuvectis Pharma?
- What is Nuvectis Pharma quarterly long term liabilities year-on-year change?
What is Nuvectis Pharma annual total long term liabilities?
The current annual total long term liabilities of NVCT is $0.00
What is the all time high annual total long term liabilities for Nuvectis Pharma?
Nuvectis Pharma all-time high annual total long term liabilities is $15.25 M
What is Nuvectis Pharma annual total long term liabilities year-on-year change?
Over the past year, NVCT annual total long term liabilities has changed by $0.00 (0.00%)
What is Nuvectis Pharma quarterly total long term liabilities?
The current quarterly long term liabilities of NVCT is $0.00
What is the all time high quarterly long term liabilities for Nuvectis Pharma?
Nuvectis Pharma all-time high quarterly total long term liabilities is $15.25 M
What is Nuvectis Pharma quarterly long term liabilities year-on-year change?
Over the past year, NVCT quarterly total long term liabilities has changed by $0.00 (0.00%)